The tech industry can expect plenty of criticism from Washington, but the two political parties don’t share all the same grievances or agree on what kind of regulatory role the government should play
The U.S. electoral calendar will likely lead to an escalation in Washington’s criticism of big tech companies this year. But politics could delay any major U.S. regulatory decision-making until after the elections are over, say legal, policy and tech experts.
To Read the Full StoryÖsterreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Alexander Ludwig on Sharing his Recovery Journey, Playing the ‘Bad Boys’ Tech GuyWith his towering height and stature, Alexander Ludwig looks every bit the action star, first appearing as Cato in “The Hunger Games,” and more recently as fierce Norse Viking chief Bjo…
Weiterlesen »
Navigating A Marketing Role In Tech: What To Look For, What To ExpectGoing to work for a tech company has a lot of appeal for marketers. However, the reality is that the experience marketers get at a tech company can differ drastically from that of other industries. This article details key questions to consider before accepting a tech role.
Weiterlesen »
The Best Travel Clothing, Luggage And Tech For Your 2020 JourneysThese are the best things I’ve found to make your travels better, easier and more comfortable.
Weiterlesen »
Tech Tax Is Just The Beginning, Says FranceFrance took a new step this week in the ongoing economic feud with the U. S., saying it won’t back down in bringing in its new tax on digital giants such as Google and Amazon.
Weiterlesen »
Casper is positioning itself as a tech company. But it's not one. - Business InsiderLike WeWork before it, Casper is trying to play up its technology bona fides. But there's little reason to believe it's really a tech company.
Weiterlesen »
Trump berates Azar over bad health care pollingThe president's frustration with his health secretary sparked a flurry of new planning on election-year drug pricing initiatives.
Weiterlesen »